Of the 1,174,018 people with diabetes, 63,620 (5.4%) were found to have undiagnosed diabetes. Wherever electronic diabetes registers are used to support the provision of care, and where blood glucose levels, HbA1c and quality-of-care data are recorded in the same system, it should be possible to identify readily (and at …
Read More »Diabetes In Control
Telemedicine Screening Finds Diabetic Retinopathy in 1 out of 5 Patients
The Innovative Network for Sight (INSIGHT) study included 1,894 people (with an average age 53 to 55 years) who were screened across the sites; 21.7 percent of the individuals were found to have DR in at least one eye, according to the study results. Background DR was the most common …
Read More »Protein in Aging Process Linked to Glucose Production
Researchers have identified a small protein with a big role in lowering plasma glucose and increasing insulin sensitivity. The report indicates that Sestrin 3 – found to operate in multiple biological processes, including resistance to oxidative and genotoxic stresses, protection against aging-related pathologies, and promotion of metabolic homeostasis – plays …
Read More »Ambio Remote Health Monitoring System
Ambio Remote Health Monitoring System The Ambio Remote Health Monitoring System, which has FDA 510(k) clearance, wirelessly sends readings from devices such as a weight scale and blood pressure and blood glucose meters to the web-based Ambio Care Portal where the readings can be viewed by patients and their authorized …
Read More »French Company Granted Rights to Implantable Pump
French Company Granted Rights to Implantable Pump Sevier, a pharmaceutical company based in France, agreed to make payments totaling over $1B to privately held Intarcia Therapeutics, Inc. for the rights to co-develop the company’s implantable pump, designed to deliver one year’s worth of the GLP-1 exenatide.
Read More »Editor’s Note, SGLT-2 Inhibitors Special Edition, November 2014
A couple of questions came up last week during a review of SGLT-2 inhibitors by my interns. The first question had to do with what was happening with SGLT-1 receptors in the research, as one of the students had remembered that there are 8 or more DPP receptors and wondered …
Read More »Letter from the Editor, #755
For the past two months our well-written fitness guru Dr. Sheri Colberg has been discussing the reasons why activity improves your brain health. This week in part 3 of the series she reveals some final details and also lets us know that the NIH is announcing a big initiative to …
Read More »Editor’s Note, DCMS #214
The prevailing statistics say that 74% of all diabetes patients have high lipids, 75% have hypertension, and that 56% of all diabetes patients have both conditions. If you take the time to read all of this week’s clinical newsletter you will learn why these statistics are so important. Our Clinical …
Read More »Editor’s Desk, GLP-1 Agonist Special Edition, November 2014
If you have never considered using a GLP-1 analog with insulin then you need to read this month’s update, and then think about how insulin and these analogs can be used together. While most of the the GLP-1’s are indicated with insulin, we don’t always think of using them before …
Read More »Handbook of Diabetes, 4th Ed., Excerpt #17: Blood Lipid Abnormalities
Rudy Bilous, MD, FRCP Richard Donnelly, MD, PHD, FRCP, FRACP Dyslipidemia in type 2 diabetes Abnormalities of blood lipids are common in patients with type 2 diabetes, even when there is reasonable glycemic control. The characteristic dyslipidemia of type 2 diabetes consists of elevated very low-density lipoprotein (VLDL) triglyceride (TG) levels, reduced …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.